Compare HON & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HON | ELV |
|---|---|---|
| Founded | 1885 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.4B | 85.7B |
| IPO Year | 2012 | 2001 |
| Metric | HON | ELV |
|---|---|---|
| Price | $226.90 | $384.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 19 |
| Target Price | $249.92 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 4.9M | 1.5M |
| Earning Date | 04-23-2026 | 04-22-2026 |
| Dividend Yield | ★ 2.26% | 1.83% |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.29 | ★ 8.00 |
| Revenue | $36,529,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $6.74 | N/A |
| Revenue Next Year | $5.91 | $3.07 |
| P/E Ratio | $172.40 | ★ $49.39 |
| Revenue Growth | ★ 12.92 | 12.49 |
| 52 Week Low | $186.76 | $273.71 |
| 52 Week High | $248.18 | $426.98 |
| Indicator | HON | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 53.47 | 44.37 |
| Support Level | $220.64 | $307.76 |
| Resistance Level | $240.80 | $408.00 |
| Average True Range (ATR) | 6.47 | 11.00 |
| MACD | 0.54 | -3.91 |
| Stochastic Oscillator | 73.12 | 5.05 |
Honeywell traces its roots to 1885 with Albert Butz's firm, Butz Thermo-Electric Regulator, which produced a predecessor to the modern thermostat. Other inventions by Honeywell include biodegradable detergent and autopilot. Today, Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. It operates through four business segments: aerospace technologies, industrial automation, energy and sustainability solutions, and building automation. Recently, Honeywell has made several portfolio changes to focus on fewer end markets and align with a set of secular growth trends. The firm is working diligently to expand its installed base, deriving around one third of its revenue from recurring aftermarket services.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.